In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.
about
Exogenous interferon-alpha and interferon-gamma increase lethality of murine inhalational anthraxMucosal damage and neutropenia are required for Candida albicans disseminationEnhancement of susceptibility of CB-17 mice to systemic candidiasis by poly(I . C)-induced interferonCharacteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans.Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis.Gamma interferon is not essential in host defense against disseminated candidiasis in miceLack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.Macrophages in resistance to candidiasisProduction and function of cytokines in natural and acquired immunity to Candida albicans infection.Effect of in vivo administration of recombinant murine gamma interferon on in vitro lymphoproliferative responses following immunization with Candida albicans.Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis.Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-γ produced in part by iNKT cells.Role of CD4+ lymphocytes in resistance to mucosal candidiasis.Candida albicans-derived mannoproteins activate NF-κB in reporter cells expressing TLR4, MD2 and CD14.
P2860
Q28396400-533839CE-81A4-4C4A-B00D-B142D8A255DBQ33320189-D5643DFF-4AB9-403B-BE52-C56E94153D8CQ33606073-E8915874-1D50-45CD-977F-957C81965345Q33752636-BAD7E308-6D7F-4BDD-87E3-0C83DA24AEDEQ34000362-D07BBEA9-9DDC-4AF4-9977-01F2A21FBB24Q35546571-175160F0-4775-4283-A287-94F2C69DDA9EQ35774193-3EDB660A-5438-4A66-9306-C7445F8DFC6CQ36574240-955ACDF8-1E59-4F00-8EAD-D0EF543C96CEQ36670422-B0B80C54-F04F-489C-8BFC-E5C75BE6D73BQ36944998-0BB011D3-0410-4112-A25D-5A8859A468D6Q36969872-9B41B7E0-D417-4A2B-84FB-5A8FE54788D7Q37582319-212F82D7-8DB2-4C91-8045-FD59B58DE5BBQ40151121-861E618B-72C3-45A6-9FD3-829A0361CE2EQ47242917-BADD5347-2EDA-4D58-8CBA-F5813E72D41E
P2860
In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
In vivo immune responses to Ca ...... inant murine gamma interferon.
@ast
In vivo immune responses to Ca ...... inant murine gamma interferon.
@en
type
label
In vivo immune responses to Ca ...... inant murine gamma interferon.
@ast
In vivo immune responses to Ca ...... inant murine gamma interferon.
@en
prefLabel
In vivo immune responses to Ca ...... inant murine gamma interferon.
@ast
In vivo immune responses to Ca ...... inant murine gamma interferon.
@en
P2093
P2860
P1476
In vivo immune responses to Ca ...... inant murine gamma interferon.
@en
P2093
C W Czarniecki
R E Garner
U Kuruganti
P2860
P304
P407
P577
1989-06-01T00:00:00Z